Stem cells in the biology of normal urothelium and urothelial carcinoma

Neoplasma

Volumn 59, Issue 6, 2012, Pages 728-736

  Hatina, J ^a   Schulz, W A ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cell culture models; Clinical risk assessment; Epithelial stromal interactions; Stem cells; Urothelial cancer; Urothelium

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 5; HERMES ANTIGEN;

BLADDER CARCINOMA; CANCER GROWTH; CANCER STEM CELL; CARCINOMA IN SITU; CELL CYCLE REGULATION; CELL HETEROGENEITY; CELL PROLIFERATION; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; INFLAMMATION; MICROENVIRONMENT; MUSCLE HYPERTROPHY; MUTATIONAL ANALYSIS; PAPILLARY CARCINOMA; REVIEW; TRANSITIONAL CELL CARCINOMA; TUMOR DIFFERENTIATION; UROTHELIUM; ANIMAL; BLADDER TUMOR; CELL COMMUNICATION; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; PATHOLOGY; PHYSIOLOGY; STROMA CELL;

ANIMALS; CELL COMMUNICATION; EPITHELIAL CELLS; HUMANS; NEOPLASTIC STEM CELLS; STROMAL CELLS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84872676126     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_089     Document Type: Review

References (43)

1. KHANDELWAL P, ABRAHAM SN., APODACA G,. Cell biology and physiology of the uroepithelium. Am. J. Physiol. Renal. Physiol. 2009; 297: F1477-501. url-http://dx.doi.org/10.1152/ajprenal.00327.2009
2. TRAN MN, GOODWIN JINESH G, MCCONKEY DJ, KAMAT AM. Bladder cancer stem cells. Curr. Stem Cell Res. Ther. 2010; 5: 387-95. url-http://dx.doi.org/10.2174/157488810793351640
3. KURZROCK EA, LIEU DK, DEGRAFFENRIED LA, CHAN CW, ISSEROFF RR. Label retaining cells of the bladder: candidate urothelial stem cells. Am. J. Physiol. Renal Physiol. 2008; 294: F1415-21. url-http://dx.doi.org/10.1152/ajprenal.00533.2007
4. BRAUN KM, WATT FM. Epidermal label retaining cells: background and recent applications. J. Investig. Dermatol. Symp. Proc. 2004; 9: 196-201. url-http://dx.doi.org/10.1111/j.1087-0024.2004.09313.x
5. TERSKIKH VV, VASILIEV AV, VOROTELYAK EA. Label retaining cells and cutaneous stem cells. Stem Cell Rev. Rep. 2011 Jul 9. doi: 10.1007/s12015-011-9299-6
6. ZHANG H, LIN G, QIU X, NING H, BANIE L et al. Label retaining and stem cell marker expression in the developing rat urinary bladder. Urology 2012; 79: 746.e1-6. doi: 10.1016/ j.urology.2011.10.051
7. TSAI YC, SIMONEAU AR, SPRUCK CH 3RD, NICHOLS PW, STEVEN K, et al. Mosaicism in human epithelium: macroscopic monoclonal patches cover the urothelium. J Urol. 1995; 153: 1697-700. url-http://dx.doi.org/10.1016/S0022-5347(01)67507-4
8. GAISA NT, GRAHAM TA, MCDONALD SA, CANADIL-LAS-LOPEZ S, POULSOM R et al. The human urothelium consists of multiple clonal units, each maintained by a stem cell. J. Pathol. 2011; 225: 163-71. url-http://dx.doi.org/10.1002/path.2945
9. CHAN KS, VOLKMER JP, WEISSMAN I. Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr. Opin. Urol. 2010; 20: 393-7. url-http://dx.doi.org/10.1097/MOU.0b013e32833cc9df
10. BARRANDON Y, GREEN H. Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl. Acad. Sci. U S A. 1987; 84: 2302-6. url-http://dx.doi.org/10.1073/pnas.84.8.2302
11. TUDOR D, CHAUDRY F, HARPER L, MACKENZIE IC. The in vitro behaviour and patterns of colony formation of murine epithelial stem cells. Cell Prolif. 2007; 40: 706-20. http://dx.doi.org/10.1111/j.1365-2184.2007.00467.x
12. THANGAPPAN R, KURZROCK EA. Three clonal types of urothelium with different capacities for replication. Cell Prolif. 2009; 42: 770-9. url-http://dx.doi.org/10.1111/j.1365-2184.2009.00647.x
13. FERLAY J, SHIN HR, BRAY F, FORMAN D, MATHERS C, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010; 127: 2893-917. url-http://dx.doi.org/10.1002/ijc.25516
14. SCHULZ WA. Understanding urothelial carcinoma through cancer pathways. Int. J. Cancer 2006; 119: 1513-8. url-http://dx.doi.org/10.1002/ijc.21852
15. MCCONKEY DJ, LEE S, CHOI W, TRAN M, MAJEWSKI T, et al. Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression. Urol. Oncol. 2010; 28: 429-40. url-http://dx.doi.org/10.1016/j.urolonc.2010.04.008 STEM CELLS IN UROTHELIUM AND UROTHELIAL CANCER 735
16. BRANDT WD, MATSUI W, ROSENBERG JE, HE X, LING S, et al. Urothelial carcinoma: stem cells on the edge. Cancer Metastasis Rev. 2009; 28: 291-304. url-http://dx.doi.org/10.1007/s10555-009-9187-6
17. DOTSIKAS G, KONOWALCHUK T, MAJOR PP, KOVAC PE, WARD GK, et al. Cellular heterogeneity in normal and neoplastic human urothelium: a study using murine monoclonal antibodies. Br. J. Cancer 1987; 56: 439-44. url-http://dx.doi.org/10.1038/bjc.1987.220
18. KUNCOVA J, KOSTROUCH Z, VIALE M, REVOLTELLA R, MANDYS V. Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197. Folia Biol. (Praha) 2005; 51: 3-11.
19. CHAN KS, ESPINOSA I, CHAO M, WONG D, AILLES L, et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor initiating cells. Proc. Natl. Acad. Sci. U S A 2009; 106: 14016-21. http://dx.doi.org/10.1073/pnas.0906549106
20. SUGINO T, GORHAM H, YOSHIDA K, BOLODEOKU J, NARGUND V, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am. J. Pathol. 1996; 149: 873-82.
21. SU Y, QIU Q, ZHANG X, JIANG Z, LENG Q, et al. Aldehyde dehydrogenase 1 A1l positive cell population is enriched in tumor initiating cells and associated with progression of bladder cancer. Cancer Epidemiol. Biomarkers Prev. 2010; 19: 327-37. url-http://dx.doi.org/10.1158/1055-9965.EPI-09-0865
22. NING ZF, HUANG YJ, LIN TX, ZHOU YX, JIANG C, et al. Subpopulations of stem like cells in side population cells from the human bladder transitional cell cancer cell line T24. J. Int. Med. Res. 2009; 37: 621-30.
23. HE K, XU T, GOLDKORN A. Cancer cells cyclically lose and regain drug resistant highly tumorigenic features characteristic of a cancer stem like phenotype. Mol. Cancer Ther. 2011; 10: 938-48. url-http://dx.doi.org/10.1158/1535-7163.MCT-10-1120
24. SHE JJ, ZHANG PG, WANG ZM, GAN WM, CHE XM. Identification of side population cells from bladder cancer cells by DyeCycle Violet staining. Cancer Biol Ther. 2008; 7: 1663-8. url-http://dx.doi.org/10.4161/cbt.7.10.6637
25. WEICHHART T, HAIDINGER M, HÖRL WH, SÄEMANN MD. Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur. J. Clin. Invest. 2008; 38 Suppl 2: 29-38. url-http://dx.doi.org/10.1111/j.1365-2362.2008.02006.x
26. MYSOREKAR IU, ISAACSON-SCHMID M, WALKER JN, MILLS JC, HULTGREN SJ. Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection. Cell Host Microbe 2009; 5: 463-75. url-http://dx.doi.org/10.1016/ j.chom.2009.04.005
27. SHIN K, LEE J, GUO N, KIM J, LIM A, QU L et al. Hedgehog/ Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 2011; 472: 110-4. url-http://dx.doi.org/10.1038/nature0
28. SANTIBANEZ JF, QUINTANILLA M, BERNABEU C. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2011; 121: 233-51. http://dx.doi.org/10.1042/CS20110086
29. WATSON S, SERRATE C, VIGNOT S. Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies (in French) Bull. Cancer 2010; 97: 1477-83.
30. HE X, MARCHIONNI L, HANSEL DE, YU W, SOOD A, et al. Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells 2009; 27: 1487-95. http://dx.doi.org/10.1002/stem.92
31. HATINA J, BUKOVINSKY O, SCHULZ WA. New cell culture models of bladder carcinoma. European J. Cancer 2010; 8 (Suppl): 136 (Abstract 21st Meeting of the European Association for Cancer Research, Oslo 2010).
32. WOO LL, TANAKA ST, ANUMANTHAN G, POPE JC 4th, THOMAS JC et al. Mesenchymal stem cell recruitment and improved bladder function after bladder outlet obstruction: preliminary data. J. Urol. 2011; 185: 1132-8. url-http://dx.doi.org/10.1016/j.juro.2010.10.033
33. DRZEWIECKI BA, THOMAS JC, TANAKA ST. Bone mar-row-derived mesenchymal stem cells: current and future applications in the urinary bladder. Stem Cells Int. 2011 Jan 3. url-http://dx.doi.org/10.4061/2010/765167
34. BITSIKA V, ROUBELAKIS MG, ZAGOURA D, TROHATOU O, MAKRIDAKIS M et al. Human Amniotic Fluid Derived Mesenchymal Stem Cells As Therapeutic Vehicles: A Novel Approach For the Treatment of Bladder Cancer. Stem Cells Dev. 2012; 21: 1097-111. url-http://dx.doi.org/10.1089/scd.2011.0151
35. MISHRA PJ, MISHRA PJ, GLOD JW, BANERJEE D Mesenchymal stem cells: flip side of the coin. Cancer Res. 2009; 69: 1255-8. doi:10.1158/0008-5472.CAN-08-3562 Correction: Cancer Res. 2009; 69: 3240. doi:10.1158/0008-5472.CAN-69-7-COR4
36. FEI DL, LI H, KOZUL CD, BLACK KE, SINGH S et al. Activation of Hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic induced tumors. Cancer Res. 2010; 70: 1981-8. url-http://dx.doi.org/10.1158/0008-5472.CAN-09-2898
37. YANG MH, HSU DS, WANG HW, WANG HJ, LAN HY et al. Bmi1 is essential in Twist1 induced epithelial mesenchymal transition. Nat. Cell Biol. 2010; 12: 982-92. url-http://dx.doi.org/10.1038/ncb2099
38. WALLERAND H, ROBERT G, PASTICIER G, RAVAUD A, BALLANGER P et al. The epithelial mesenchymal transition inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers. Urol. Oncol. 2010; 28: 473-9. url-http://dx.doi.org/10.1016/j.urolonc.2008.12.018
39. YU H, PARDOLL D, JOVE R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009; 9: 798-809. url-http://dx.doi.org/10.1038/nrc2734
40. CHANG CC, SHIEH GS, WU P, LIN CC, SHIAU AL et al. Oct 3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res. 2008; 68: 6281-91. http://dx.doi.org/10.1158/0008-5472.CAN-08-0094 736 J. HATINA, W. A. SCHULZ
41. HUANG P, CHEN J, WANG L, NA Y, KAKU H et al. Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence. Med. Oncol. 2012; 29: 829-34. url-http://dx.doi.org/10.1007/s12032-011-9962-4
42. VOLKMER JP, SAHOO D, CHIN RK, HO PL, TANG C et al. Three differentiation states risk stratify bladder cancer into distinct subtypes. Proc. Natl. Acad. Sci. U S A 2012; 109: 2078-83. url-http://dx.doi.org/10.1073/pnas.1120605109
43. SEIFERT HH, MEYER A, CRONAUER MV, HATINA J, MULLER M et al. A new and reliable culture system for superficial low grade urothelial carcinoma of the bladder. World J. Urol. 2007; 25: 297-302. url-http://dx.doi.org/10.1007/s00345-007-0166-7